VAD clinic visit study for new and returning patients
Part of Heart & circulation clinical trials.
This trial looks at how well a specialized, multidisciplinary clinic works for people who have a ventricular assist device (VAD) and compares new VAD patients with those who have already had standard follow-up visits. It may help improve how care and check-ins are organized after your VAD is implanted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older
- You have a ventricular assist device (VAD)
- You fit either the “new to follow-up clinic” group or the “already had follow-up visits” group
- You can complete quality-of-life questionnaires (survey questions about how you feel)
- You can do a 6-minute walk test
- You can do a heart/lung exercise test called CPET
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called V-Lap that is placed in the heart to monitor pressure. It may help doctors better manage heart failure and reduce hospital stays. Researchers want to see if it works well in people with mild to moderate heart failure.
This trial tests whether a home, virtual-care program after a recent heart failure hospital visit can improve recovery and outcomes. You may be invited if you recently left the hospital for heart failure and meet specific heart and lab test thresholds.
This study tests a new outpatient care approach for people with heart failure to help manage symptoms like shortness of breath and fluid buildup. You may be eligible if you are stable enough to attend visits and meet specific heart failure and lab/imaging criteria.
This study looks at how well continuous-flow heart pumps (VADs) work in people with advanced heart failure. It aims to improve care and outcomes for adults receiving these devices.
This trial tests if a combination of a tiny lung-artery pressure sensor (CardioMEMS) and a mechanical heart pump (HeartMate 3) is safe and effective for people with advanced heart failure. If you qualify, you'll either get the heart pump plus standard medical therapy, or continue with standard therapy alone and have your pressure monitored remotely.
This trial tests a device that treats and monitors heart failure. It may help people with chronic heart failure and reduced heart function who still have symptoms despite standard treatments.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.